Lawrence M Alleva - Net Worth and Insider Trading
Lawrence M Alleva Net Worth
The estimated net worth of Lawrence M Alleva is at least $3 Million dollars as of 2024-11-10. Lawrence M Alleva is the Director of Tesaro Inc and owns about 29,902 shares of Tesaro Inc (TSRO) stock worth over $2 Million. Lawrence M Alleva is the Director of Bright Horizons Family Solutions Inc and owns about 9,362 shares of Bright Horizons Family Solutions Inc (BFAM) stock worth over $1 Million. Lawrence M Alleva is also the Director of Adaptimmune Therapeutics PLC and owns about 117,864 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $93,926. Besides these, Lawrence M Alleva also holds Mersana Therapeutics Inc (MRSN) , Galera Therapeutics Inc (GRTX) . Details can be seen in Lawrence M Alleva's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence M Alleva has not made any transactions after 2023-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence M Alleva
Lawrence M Alleva Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence M Alleva owns 6 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , Mersana Therapeutics Inc (MRSN) , and Bright Horizons Family Solutions Inc (BFAM) among others .
Click here to see the complete history of Lawrence M Alleva’s form 4 insider trades.
Insider Ownership Summary of Lawrence M Alleva
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2020-06-09 | director |
| MRSN | Mersana Therapeutics Inc | 2020-06-01 | director |
| BFAM | Bright Horizons Family Solutions Inc | 2023-12-01 | director |
 | | 2021-06-01 | director |
| | 2019-01-22 | director |
| | 2015-09-30 | director |
Lawrence M Alleva Latest Holdings Summary
Lawrence M Alleva currently owns a total of 5 stocks. Among these stocks, Lawrence M Alleva owns 29,902 shares of Tesaro Inc (TSRO) as of June 12, 2018, with a value of $2 Million and a weighting of 65.42%. Lawrence M Alleva owns 9,362 shares of Bright Horizons Family Solutions Inc (BFAM) as of December 1, 2023, with a value of $1 Million and a weighting of 31.74%. Lawrence M Alleva also owns 117,864 shares of Adaptimmune Therapeutics PLC (ADAP) as of June 9, 2020, with a value of $93,926 and a weighting of 2.74%. The other 2 stocks Mersana Therapeutics Inc (MRSN) , Galera Therapeutics Inc (GRTX) have a combined weighting of 0.1% among all his current holdings.
Latest Holdings of Lawrence M Alleva
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSRO | Tesaro Inc | 2018-06-12 | 29,902 | 74.96 | 2,241,454 |
| BFAM | Bright Horizons Family Solutions Inc | 2023-12-01 | 9,362 | 116.14 | 1,087,303 |
| ADAP | Adaptimmune Therapeutics PLC | 2020-06-09 | 117,864 | 0.80 | 93,926 |
| MRSN | Mersana Therapeutics Inc | 2020-06-01 | 1,085 | 2.57 | 2,788 |
| GRTX | Galera Therapeutics Inc | 2021-06-01 | 10,370 | 0.05 | 550 |
Holding Weightings of Lawrence M Alleva
Lawrence M Alleva Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence M Alleva has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the sale of 7,142 shares on June 12, 2018, which brought Lawrence M Alleva around $307,892.
According to the SEC Form 4 filings, Lawrence M Alleva has made a total of 2 transactions in Bright Horizons Family Solutions Inc (BFAM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Bright Horizons Family Solutions Inc is the sale of 680 shares on December 1, 2023, which brought Lawrence M Alleva around $60,241.
According to the SEC Form 4 filings, Lawrence M Alleva has made a total of 1 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 12,900 shares on June 9, 2020, which cost Lawrence M Alleva around $24,381.
More details on Lawrence M Alleva's insider transactions can be found in the Insider Trading History of Lawrence M Alleva table.Insider Trading History of Lawrence M Alleva
- 1
Lawrence M Alleva Trading Performance
GuruFocus tracks the stock performance after each of Lawrence M Alleva's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lawrence M Alleva is 7.02%. GuruFocus also compares Lawrence M Alleva's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lawrence M Alleva within 3 months outperforms 10 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lawrence M Alleva's insider trading performs compared to the benchmark.
Performance of Lawrence M Alleva
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.73 | | | | | |
| Relative Return to S&P 500(%) | 7.21 | | | | | |
Lawrence M Alleva Ownership Network
Ownership Network List of Lawrence M Alleva
Ownership Network Relation of Lawrence M Alleva
Lawrence M Alleva Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Lawrence M Alleva is the director of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Lawrence M Alleva made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Lawrence M Alleva Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence M Alleva. You might contact Lawrence M Alleva via mailing address: 1000 Winter Street, Suite 3300, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
